Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
5.77M
-
Shares change
-
+141K
-
Total reported value, excl. options
-
$29.9M
-
Value change
-
+$748K
-
Put/Call ratio
-
1.85
-
Number of buys
-
7
-
Number of sells
-
-9
-
Price
-
$5.17
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q2 2024
27 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q2 2024.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.77M shares
of 13.8M outstanding shares and own 41.72% of the company stock.
Largest 10 shareholders include Battery Management Corp. (2.42M shares), NEA Management Company, LLC (1.71M shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (685K shares), VANGUARD GROUP INC (307K shares), RENAISSANCE TECHNOLOGIES LLC (123K shares), BlackRock Inc. (116K shares), GOLDMAN SACHS GROUP INC (69.3K shares), GEODE CAPITAL MANAGEMENT, LLC (63.1K shares), MORGAN STANLEY (43.1K shares), and NORTHERN TRUST CORP (40.5K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.